A Multicenter, Adaptive, Randomized Blinded Controlled Trial of the Safety and Efficacy of Investigational Therapeutics for the Treatment of COVID-19 in Hospitalized Adults

This study tested new medicines to see how well they help hospitalized adults recover from COVID-19. By comparing different treatments against a placebo, researchers aimed to find faster and safer ways to help patients get better.

The study was designed for adults 18 and older who were recently diagnosed with COVID-19 and were currently in the hospital. Participants had to be stable enough not to require a ventilator or significant breathing assistance at the start of the study.

Participants were randomly assigned to receive either an investigational medicine or a placebo, which is a substance that contains no medicine. Doctors monitored everyone closely throughout their hospital stay to see how quickly they recovered and to ensure their safety.

The study took place at multiple locations, including Birmingham, Alabama, and La Jolla and Los Angeles, California. This trial is now officially completed.